Creo Medical Group PLC (AIM:CREO, OTC:CMEOF) will hold a Capital Markets Day for investors and analysts at 2:30 pm on Wednesday, 19 November in the City of London. The AIM-listed medical device company focuses on minimally invasive surgical endoscopy technologies for pre-cancer and cancer treatment. The event follows its earlier announcement on 7 October 2025.
To register your interest, please contact Walbrook PR on 020 7933 8780 or creo@walbrookpr.com.